PCM
SEM

Peregrine Capital Management’s Select Medical SEM Stock Holding History

Peregrine Capital Management’s Portfolio SEM Stock Details SEM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q1 		– Sell
-1,187,541
Closed -$8.48M – 258
2016
Q4 		$8.48M Sell
1,187,541
-98,064
-8% -$683K 0.22% 213
2016
Q3 		$9.35M Buy
+1,285,605
New +$8.17M 0.24% 187

Other funds holding SEM

T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
NTC
North Tide Capital Boston, Massachusetts $469M AUM 6.57% 1-Year Est. Return
CCM
Camber Capital Management Boston, Massachusetts $1.07B AUM 8.19% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
JP
Jana Partners New York $1.34B AUM 4.95% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Peregrine Capital Management's SEM Position: Q1 2017 in Review

Peregrine Capital Management sold out of Select Medical (SEM) in Q1 2017, closing a stake of 1,187,541 shares — an estimated $8.48M sold.

Peregrine Capital Management first reported a position in SEM in Q3 2016 and held it in 2 quarters. The position peaked at $9.35M in Q3 2016. 164 funds tracked by Wall St. Rank hold SEM as of Q1 2017.

  • Peregrine Capital Management reported no remaining Select Medical position as of Q1 2017 after selling out during the quarter.
  • Peregrine Capital Management sold 1,187,541 Select Medical shares in Q1 2017, an estimated $8.48M.
  • Peregrine Capital Management first reported a position in Select Medical in Q3 2016 and held it in 2 quarters.
  • Peregrine Capital Management's Select Medical position peaked at $9.35M in Q3 2016.
  • 164 funds tracked by Wall St. Rank held Select Medical as of Q1 2017.

Based on Peregrine Capital Management's 13F filing for Q1 2017, filed 7 Apr 2017.